Predicting Treatment Failure in Diffuse Large B-Cell Lymphoma Patients
Builds a simple test to spot lymphoma patients at high risk of treatment failure.
Plain-language title generated from the registry record
Registry title: Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
Key facts
- Where
- Göttingen, GermanySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06526065, who can take part
Where in Germany
- Universitätsmedizin GöttingenGöttingen, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Medical Center Goettingen
- Trial code
- NCT06526065
- Record updated
- 29 July 2024
- Original description
The trial aims at the construction and validation of an accurate, affordable and simple prognostic tool to be used in everyday clinical practice, which allows the early and reliable identification of DLBCL patients who have a very high risk of treatment failure following R-CHOP/-like first-line therapy.Read full original descriptionShow less
Molecular Mechanisms in Malignant Lymphoma- Predict
The trial aims at the construction and validation of an accurate, affordable and simple prognostic tool to be used in everyday clinical practice, which allows the early and reliable identification of DLBCL patients who have a very high risk of treatment failure following R-CHOP/-like first-line therapy.
Inclusion: Histological diagnosis of DLBCL\&LBCL; Planned treatment with guideline-based first-line therapy; Patient's consent; All genders, Patient age ≥ 18 years; Ability to consent.
Exclusion: Treatment with R-CHOP/-like regimens already started; Active HIV-infection; Presence history of other active cancers (with the exception of basal cell carcinoma of the skin); Relationship of dependence/ direct employment with the investigator.